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Background: In Oregon, human and animal infections by C. gattii were first identified in 2004. Cryptococcus gattii is
considered to be an emerging non-zoonotic infection affecting animals and humans in Oregon. We report a
longitudinal environmental isolation of C. gattii after an Oregon dog was diagnosed with the disease in 2009.
Results: Cryptococcus gattii was isolated twice from the same location with a span of one year between isolation
dates. Cryptococcus gattii molecular types VGIIa and VGI were isolated in 2010 from soil and tree bark near the
home of a 9-month-old dog which three months previously had an infection caused by C. gattii genotype VGIIa.
The environment featured heavy growth of Douglas Fir trees. In 2011, a second set of soil and tree bark samples
was collected in the same area and C. gattii VGIIa was again identified from the environment, along with genotypes
VGIIb and VGIIc.
Conclusions: The use of animal surveillance data to identify environmental niches of C. gattii should be considered
to expand the understanding of this emerging pathogen. Understanding the ecology and how the environment
and other factors might modify the existing niches is important for assessing risk and for designing measures to
protect human and animal health.Background
Infection by the fungus Cryptococcus causes pneumonia,
skin infection and meningoencephalitis [1-7]. While C.
neoformans is the most common cause of fatal meningo-
encephalitis, especially in HIV patients, C. gattii has
caused disease mainly in non-HIV patients [8]. In 1999,
C. gattii infections emerged on Vancouver Island, British
Columbia (BC). Nearly all infections were caused by C.
gattii genotype VGII, but the strains lacked the genetic
diversity seen among other VGII isolates from other
countries and appeared to represent distinct clonal pop-
ulations, dubbed genotypes VGIIa and VGIIb [9,10].
During subsequent years, C. gattii spread to the BC
mainland. In Oregon, human and animal infections by
C. gattii were first identified in 2004, and they have sub-
sequently been identified in Washington State as well
[11]. Interestingly, Cryptococcus gattii genotype VGIIc,
which had not been identified in BC, has been diagnosed* Correspondence: emilio.e.debess@state.or.us
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unless otherwise stated.in animals and humans in the US Pacific Northwest
(PNW) and seems to be centered in Oregon [12,13].
The only known means of acquisition of C. gattii in-
fection is inhalation of spores from the environment. Es-
timation of the incubation period became possible with
the identification of a focal reservoir of the fungus on
Vancouver Island; an analysis of early cases among resi-
dents of the BC mainland with discreet histories of travel
to Vancouver Island found incubation periods ranging
from 2 to 13 months, with a median of 6–7 months [6,7].
From December 2004 through December 2012, 82 hu-
man cases of C. gattii infection were reported in Oregon,
but early attempts to isolate the fungus from the envir-
onment around Oregon case residences were unsuccess-
ful [14]. In 2008, reporting of cryptococcal infection
among animals in Oregon became mandatory for veteri-
narians and veterinary laboratories and 67 animal cases
were identified through December 2012 — 28 cats, 16
dogs, 8 alpacas, 7 goats, 3 elk, 2 ferrets, 1 horse, 1 sheep
and 1 porpoise. The identification of C. gattii infection
in domestic animals suggested that exposure to the fun-
gus must have occurred near the animals’ residence and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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C. gattii in Oregon.
In March 2010, a 9-month old dog in northwestern
Oregon, without travel history, presented to a specialty
clinic for examination of periorbital swelling. The animal
was in good health except for the swelling. The attend-
ing veterinarian obtained a biopsy sample of the perior-
bital area for cytology and culture. The culture yielded
Cryptococcus, and the isolate was sent to Oregon State
University, Veterinary Diagnostics Laboratory (OSU, VDL)
for further identification. It was identified as C. gattii,
genotype VGIIa. The dog lived in a rural area at 177 feet
elevation, heavily populated primarily with Douglas fir
trees (Pseudotsuga menziesii). The property is located less
than 30 feet from an unpaved logging road where several
times a day logging trucks carry recently harvested
Douglas Firs (Figure 1). This report describes the results
of environmental sampling around this case.
Methods
Environmental sampling was conducted in June 2010 at
selected sites and areas surrounding the home environ-
ment of the dog with C. gattii infection. Sampled environ-
ments included areas frequented by the dog, including
front and back yards, ditches, a rabbit farm and walking
trails. Samples of tree bark (~10 g), woody debris (10–
20 g), soil (50 g), and water (50–100 mL) were sampled as
described by Kidd et al. [14]. Samples were placed in ster-
ile transport bags and stored in the dark at 4°–10°C pend-
ing transfer to the laboratory. Two grams of each sample
were suspended in sterile water, and the mixture wasFigure 1 Geographical location of C. gattii environmental samples, Orvortexed and allowed to settle for 10 minutes. Four 200-
μL aliquots of each sample were plated on L-3,4-dihydrox-
yphenylalanine (DOPA) medium and incubated at 35°C
for up to two weeks. Between one and six colonies were
picked from each environmental positive sample and all
picked colonies were genotyped. C gattii was confirmed
using L-canavanine-glycine-bromothymol blue (CGB) dif-
ferential medium [15], and every isolate picked was geno-
typed using multilocus sequence typing as described [14].
A year later, May 2011, samples of soil and tree bark
were again collected in the same area and at an add-
itional location along the logging road.
Results
Of the 12 samples obtained in 2010 around the home of
the positive veterinary case, two yielded C. gattii; one
soil sample had genotype VGIIa isolates, and another
had isolates of both VGIIa and VGI (Table 1). Upon re-
turn to the same environs in 2011, C. gattii isolates of
genotypes VGIIa, VGIIb and VGIIc were identified from
the bark and soil samples taken along the logging road
bordering the same property. The C. gattii VGIIa iso-
lates from soil and bark were indistinguishable from the
VGIIa isolate obtained from the dog.
Conclusion
This is the only longitudinal record of C. gattii from the
environment in Oregon from the environs of a positive
case. As was the experience in Vancouver [10], isolation
in Oregon was associated with Douglas Fir trees and ex-
tends the ecological niche of C. gattii in this biogeoclimaticegon 2010–2011.
Table 1 Cryptococcus gattii environmental sampling
results in the surroundings of a positive veterinary case,
Oregon, 2010–2011
Year Genotype Location of sampling Site #
2010 VGIIa Canine periorbital abscess
2010 VGI Soil, wet ditch by road 1
2010 VGIIa Soil, rabbit farm 2
2010 Negative Soil, rabbit farm 2
2010 VGIIa Soil, dry ditch road 3
2010 Negative Soil edge of logging road 4
2010 Negative Soil edge of logging road 4
2011 VGIIa Soil, dry ditch by road 3
2011 VGIIc Tree bark, dirt logging road 5
2011 VGIIc Douglas Fir Tree bark 5
2011 VGIIa Soil, wet ditch by road 1
2011 VGIIa Soil, wet ditch by road 1
2011 VGIIa Soil, wet ditch by road 1
2011 VGIIc Soil, wet ditch by road 1
2011 VGIIa Douglas Fir Tree Bark, rabbit farm 2
2011 VGIIa Douglas Fir Tree Bark, rabbit farm 2
2011 VGIIa Douglas Fir Tree Bark, rabbit farm 2
2011 VGIIa Douglas Fir Tree Bark, rabbit farm 2
2011 VGIIa Douglas Fir Tree Bark, rabbit farm 2
2011 VGIIb Douglas Fir Tree Bark, rabbit farm 2
2011 Negative Soil, dry ditch by road 3
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Valley of Oregon. In BC, C. gattii was generally isolated
from acidic soil, and geographic differences in soil pH may
influence the extent of colonization reported. Cryptococcus
gattii soil colonization also was associated with low mois-
ture and low organic carbon contents although one of our
positive soil samples came from a standing puddle. The
role that trees play in the life cycle of C. gattii is not
known, but the association of the fungus with decaying
wood, especially Douglas Fir in the Pacific Northwest, but
also many other species of tree is suggestive of an endo-
phytic existence [14,16].
Perhaps because of the long potential incubation period,
during which individual human cases may be exposed to a
variety of biogeoclimatic areas, pinpointing environmental
niches for C. gattii has proven difficult. After extensive
sampling around human cases in Australia, Ellis and
Pfeiffer reported the first environmental isolation of the
fungus in 1990 from eucalyptus trees and noted that the
distribution of cases was similar to that of eucalyptus trees
[17]. In BC, C. gattii has been isolated from a variety of
trees and from soil samples in Coastal Douglas Fir and in
the Coastal Western Hemlock xeric maritime biogeoclimaticzones. Similar climatic areas are found in Oregon’s
Willamette Valley [18]. The C. gattii zone may be expand-
ing, accentuated by the increase of logging in the coastal
temperate rain forest zone which continues to be wide-
spread, generally beginning in the easily accessible low-
lands and working upslope.
Three features are common to all coastal temperate
rain forests: proximity to oceans, the presence of moun-
tains, and as a result of the two, high rainfall [19].
Isolating C. gattii from the environment has been chal-
lenging in other areas of the PNW [14,17] (R. Wohrle,
personal communication), perhaps because cases may
have been exposed far from their residences making pin-
pointing areas to sample difficult. This is the first time
that four different genotypes (VGI, VGIIa, VGIIb, and
VGIIc) have been isolated from the same general envir-
ons. It is important to mention that in our experience, if
only a single colony had been genotyped from each
plate, we may have missed the genotypes VGI, VGIIb
and VGIIc, all of which were isolated from the same
samples that contained isolates of VGIIa. The diversity
of VGIIa isolates from the PNW is so narrow that even
isolates from hundreds of miles apart only have on aver-
age 12 single nucleotide polymorphisms between them
out of 34,000,000 million nucleotides in the genome
[20]. With this high level of clonality, it is nearly impos-
sible to determine the source of a single infection as all
of the isolates are nearly identical. Whole-genome se-
quencing on C. gattii isolates will better ascertain the
natural source and genomic adaptations of the infection
in the Pacific Northwest. Based on a recent study VGII
study was highly diverse, demonstrating large numbers
of mutational and recombinant events. The three dom-
inant subtypes in the Pacific Northwest were low diver-
sity and completely clonal [20].
The use of animal surveillance to identify environmen-
tal sources of the disease should be considered to ex-
pand understanding of C. gattii environmental niches, as
they are ultimately the source of animal and human in-
fections. Although rare, C. gattii appears to be an emer-
ging pathogen and understanding the ecological niches
and how environmental or other factors might modify
the existing niches is important for assessing risk and for
designing measures to protect human and animal health.
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